StageZero Life Sciences



Direct Communication Solutions, Inc.
Latest Comments
image_pdfimage_print

StageZero on revenues being generated via testing operations, partners and a status report on the Aristotle test

In a recent InvestorIntel interview, Tracy Weslosky speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX: […]


StageZero Life Sciences’ Aristotle 10 in 1 cancer screening test looks set to launch in Q1 2021

StageZero Life Sciences Ltd. (TSX: SZLS) (‘StageZero’) has been developing their Aristotle 10 in 1 cancer screening test for about […]


Kozak on StageZero: Come for COVID, stay for the cancer testing

“15 years of work”, is how StageZero Life Sciences Ltd. (TSX: SZLS) Chairman and CEO James Howard-Tripp described why he […]


StageZero Saliva PCR Test, a potential game changer for replacing the nasal probe

Nobody likes a COVID-19 nasal swab test that pushes a probe way up into your nose nearly reaching your brain. […]


Early cancer detection in the spotlight in the wake of actor Chadwick Boseman’s tragic death

New technology offers hope for early detection and survivability The recent passing of Black Panther star Chadwick Boseman at only […]


James Howard-Tripp on applying StageZero’s cancer diagnostics expertise to COVID-19 testing

InvestorIntel’s Tracy Weslosky talks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX: SZLS), about StageZero’s early […]


StageZero Life Sciences up 177% YTD as they move into COVID-19 testing

As global COVID-19 cases hit a staggering 5 million, StageZero Life Sciences Ltd. (TSX: SZLS) stock price has surged 177% […]